Patient info Open main menu

Rivaroxaban Umedica 2.5 mg film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
2.5 mg
Contains active substance:
Similar medicines:

Patient leaflet - Rivaroxaban Umedica 2.5 mg film-coated tablets

1. What Rivaroxaban Umedica is and what it is used for

You have been given Rivaroxaban Umedica because

  • you have been diagnosed with an acute

    coronary syndrome (a group of conditions that includes heart attack and unstable angina, a severe type of chest pain) and have been shown to have had an increase in certain cardiac blood tests.

    This medicine reduces the risk in adults of having another heart attack or reduces the risk of dying from a disease related to your heart or your blood vessels.

    Rivaroxaban Umedica will not be given to you on its own. Your doctor will also tell you to take either:

    Ÿ acetylsalicylic acid or

    Ÿ acetylsalicylic acid plus clopidogrel or ticlopidine.

    Or

  • you have been diagnosed with a high risk of

    getting a blood clot due to a coronary artery disease or peripheral artery disease which causes symptoms.

    This medicine reduces the risk in adults of getting blot clots (atherothrombotic events). Rivaroxaban Umedica will not be given to you on its own. Your doctor will also tell you to take acetylsalicylic acid.

    In some cases, if you get Rivaroxaban Umedica after a procedure to open a narrowed or closed artery of your leg to restore blood flow, your doctor may also prescribe clopidogrel for you to take in addition to acetylsalicylic acid for a short while.

This medicine contains the active substance rivaroxaban and belongs to a group of medicines called antithrombotic agents. It works by blocking a blood clotting factor (factor Xa) and thus reducing the tendency of the blood to form clots.

2. What you need to know before you take Rivaroxaban Umedica

Do not take Rivaroxaban Umedica

Ÿ if you are allergic to rivaroxaban or any of

the other ingredients of this medicine (listed in section 6)

Ÿ if you are bleeding excessively

Ÿ if you have a disease or condition in an

organ of the body that increases the risk of serious bleeding (e.g. stomach ulcer, injury or bleeding in the brain, recent surgery of the brain or eyes)

Ÿ if you are taking medicines to prevent

blood clotting (e.g. warfarin, dabigatran, apixaban or heparin), except when changing anticoagulant treatment or while getting heparin through a venous or arterial line to keep it open

Ÿ if you have an acute coronary syndrome

and previously had a bleeding or a blood clot in your brain (stroke)

Ÿ if you have coronary artery disease or

peripheral artery disease and previously had a bleeding in your brain (stroke) or where there was a blockage of the small arteries providing blood to the brain's deep tissues (lacunar stroke) or if you had a blood clot in your brain (ischaemic, non- lacunar stroke) in the previous month

Ÿ if you have a liver disease which leads to an

increased risk of bleeding

Ÿ if you are pregnant or breast-feeding Do not take Rivaroxaban Umedica and tell your doctor if any of these apply to you.

Warnings and precautions

Talk to your doctor or pharmacist before taking Rivaroxaban Umedica.

This medicine should not be used in

combination with certain other medicines which reduce blood clotting such as prasugrel or ticagrelor other than acetylsalicylic acid and clopidogrel/ticlopidine.

Take special care with Rivaroxaban Umedica

Ÿ if you have an increased risk of bleeding, as

could be the case in situations such as: § severe kidney disease, since your kidney function may affect the amount of medicine that works in your body § if you are taking other medicines to prevent blood clotting (e.g. warfarin, dabigatran, apixaban or heparin), when changing anticoagulant treatment or while getting heparin through a venous or arterial line to keep it open (see section “Other medicines and Rivaroxaban Umedica”)

§ bleeding disorders

§ very high blood pressure, not controlled by medical treatment

§ diseases of your stomach or bowel that might result in bleeding, e.g.

inflammation of the bowels or stomach, or inflammation of the oesophagus (gullet), e.g. due to gastroesophageal reflux disease (disease where stomach acid goes upwards into the oesophagus) or tumours located in the stomach or bowels or genital tract or urinary tract § a problem with the blood vessels in the back of your eyes (retinopathy) § a lung disease where your bronchi are widened and filled with pus

(bronchiectasis), or previous bleeding from your lung

§ you are older than 75 years

§ you weigh less than 60 kg

§ you have a coronary artery disease with severe symptomatic heart failure Ÿ if you have a prosthetic heart valve Ÿ if you have cancer:

Some cancers, especially those in the

stomach, intestines, bladder, or kidneys, may increase your risk of bleeding when taking this medicine.

Your doctor will carefully consider whether

this medicine is suitable for you, depending on your type of cancer and treatment Ÿ if you know that you have a disease called

antiphospholipid syndrome (a disorder of the immune system that causes an increased risk of blood clots), tell your doctor who will decide if the treatment may need to be changed.

If any of the above apply to you, tell your doctor before you take this medicine. Your doctor will decide, if you should be treated with this medicine and if you should be kept under closer observation.

If you need to have an operation

Ÿ it is very important to take this medicine

before and after the operation exactly at the times you have been told by your doctor. Ÿ If your operation involves a catheter or

injection into your spinal column (e.g. for epidural or spinal anaesthesia or pain reduction):

§ it is very important to take Rivaroxaban Umedica before and after the injection or removal of the catheter exactly at the times you have been told by your doctor § tell your doctor immediately if you get numbness or weakness of your legs or problems with your bowel or bladder after the end of anaesthesia, because urgent care is necessary.

Children and adolescents

Rivaroxaban Umedica are not recommended for people under 18 years of age. There is not enough information on their use in children and adolescents.

Other medicines and Rivaroxaban Umedica

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.

Ÿ If you are taking

§ some medicines for fungal infections (e.g. fluconazole, itraconazole, voriconazole, posaconazole), unless they are only applied to the skin

§ ketoconazole tablets (used to treat Cushing's syndrome - when the body produces an excess of cortisol) § some medicines for bacterial infections (e.g. clarithromycin, erythromycin) § some anti-viral medicines for HIV / AIDS (e.g. ritonavir)

§ other medicines to reduce blood clotting (e.g. enoxaparin, clopidogrel or vitamin K antagonists such as warfarin and acenocoumarol, prasugrel and ticagrelor (see section “Warnings and

Precautions”))

§ anti-inflammatory and pain relieving medicines (e.g. naproxen or

acetylsalicylic acid)

§ dronedarone, a medicine to treat abnormal heart beat

§ some medicines to treat depression (selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs))

If any of the above apply to you, tell your doctor before taking Rivaroxaban Umedica, because the effect of this medicine may be increased. Your doctor will decide, if you should be treated with this medicine and if you should be kept under closer observation.

If your doctor thinks that you are at increased risk of developing stomach or bowel ulcers, he may also use a preventative ulcer treatment. Ÿ If you are taking

§ some medicines for treatment of epilepsy (phenytoin, carbamazepine,

phenobarbital)

§ St John's Wort (Hypericum perforatum), a herbal product used for depression § rifampicin, an antibiotic

If any of the above apply to you, tell your doctor before taking Rivaroxaban Umedica, because the effect of this medicine may be reduced. Your doctor will decide, if you should be treated with Rivaroxaban Umedica and if you should be kept under closer observation.

Pregnancy and breast-feeding

Do not take this medicine if you are pregnant or breast-feeding. If there is a chance that you could become pregnant, use a reliable contraceptive while you are taking Rivaroxaban Umedica. If you become pregnant while you are taking this medicine, tell your doctor immediately, who will decide how you should be treated.

Driving and using machines

This medicine may cause dizziness (common side effect) or fainting (uncommon side effect) (see section 4,”Possible side effects”). You should not drive, ride a bicycle or use any tools or machines if you are affected by these symptoms.

Rivaroxaban Umedica contains lactose and sodium

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ”sodium- free”.

3. How to take Rivaroxaban Umedica

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

How much to take

The recommended dose is one 2.5 mg tablet twice a day. Take Rivaroxaban Umedica around the same time every day (for example, one tablet in the morning and one in the evening). This medicine can be taken with or without food. If you have difficulty swallowing the tablet whole, talk to your doctor about other ways to take this medicine. The tablet may be crushed and mixed with water or apple puree immediately before you take it.

Rivaroxaban Umedica 2.5 mg film-coated tablets

(PIL Size: 140x570 MM)

Rivaroxaban Umedica 2.5 mg film-coated tablets

r i v

a r o

x a b

a

nrivaroxaban

Package leaflet: Information for the user

Umedica Laboratories UK Ltd

If necessary, your doctor may also give you the crushed Rivaroxaban Umedica tablet through a stomach tube.

Rivaroxaban Umedica will not be given to you on its own.

Your doctor will also tell you to take acetylsalicylic acid.

If you get this medicine after an acute coronary syndrome, your doctor may tell you to also take clopidogrel or ticlopidine.

If you get Rivaroxaban Umedica after a procedure to open a narrowed or closed artery of your leg to restore blood flow, your doctor may also prescribe clopidogrel for you to take in addition to acetylsalicylic acid for a short while. Your doctor will tell you how much of these to take (usually between 75 to 100 mg acetylsalicylic acid daily or a daily dose of 75 to 100 mg acetylsalicylic acid plus a daily dose of either 75 mg clopidogrel or a standard daily dose of ticlopidine).

When to start Rivaroxaban Umedica

Treatment with this medicine after an acute coronary syndrome should be started as soon as possible after stabilisation of the acute coronary syndrome, at the earliest 24 hours after admission to hospital and at the time when parenteral (via injection) anticoagulation therapy would normally be stopped.

Your doctor will tell you when to start treatment with Rivaroxaban Umedica if you have been diagnosed with coronary artery disease or peripheral artery disease.

Your doctor will decide how long you must continue treatment.

If you take more Rivaroxaban Umedica than you should

Contact your doctor immediately if you have taken too many Rivaroxaban Umedica. Taking too much Rivaroxaban Umedica increases the risk of bleeding.

If you forget to take Rivaroxaban Umedica

Do not take a double dose to make up for a missed dose. If you miss a dose, take your next dose at the usual time.

If you stop taking Rivaroxaban Umedica

Take this medicine on a regular basis and for as long as your doctor keeps prescribing it. Do not stop taking this medicine without talking to your doctor first. If you stop taking this medicine, it may increase your risk of having another heart attack or stroke or dying from a disease related to your heart or your blood vessels.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, Rivaroxaban Umedica can cause side effects, although not everybody gets them.

Like other similar medicines to reduce the formation of blood clots, this medicine may cause bleeding which may potentially be life threatening. Excessive bleeding may lead to a sudden drop in blood pressure (shock). In some cases the bleeding may not be obvious. Tell your doctor immediately if you experience any of the following side effects:

Ÿ Signs of bleeding

  • bleeding into the brain or inside the skull (symptoms can include headache, one-sided weakness, vomiting, seizures, decreased level of consciousness, and neck stiffness.

    A serious medical emergency. Seek medical attention immediately!)

  • long or excessive bleeding
  • exceptional weakness, tiredness, paleness, dizziness, headache, unexplained swelling, breathlessness, chest pain or angina pectoris

Your doctor may decide to keep you under closer observation or change the treatment. Ÿ Signs of severe skin reactions

  • spreading intense skin rash, blisters or mucosal lesions, e.g. in the mouth or eyes (Stevens-Johnson syndrome/toxic epidermal necrolysis).
  • a drug reaction that causes rash, fever, inflammation of internal organs, blood abnormalities and systemic illness (DRESS syndrome).

The frequency of these side effects is very rare (up to 1 in 10,000 people).

Ÿ Signs of severe allergic reactions

  • swelling of the face, lips, mouth, tongue or throat; difficulty swallowing; hives and breathing difficulties; sudden drop in blood pressure.

The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic oedema; may affect up to 1 in 100 people).

Overall list of possible side effects Common (may affect up to 1 in 10 people)

  • reduction in red blood cells which can

    make the skin pale and cause weakness or breathlessness

  • bleeding in the stomach or bowel,

    urogenital bleeding (including blood in the urine and heavy menstrual bleeding), nose bleed, bleeding in the gum

  • bleeding into the eye (including bleeding

    from the whites of the eyes)

  • bleeding into tissue or a cavity of the body

    (haematoma, bruising)

  • coughing up blood
  • bleeding from the skin or under the skin
  • bleeding following an operation
  • oozing of blood or fluid from surgical

    wound

  • swelling in the limbs
  • pain in the limbs
  • impaired function of the kidneys (may be

    seen in tests performed by your doctor)

  • fever
  • stomach ache, indigestion, feeling or being

    sick, constipation, diarrhea

  • low blood pressure (symptoms may be

    feeling dizzy or fainting when standing up)

  • decreased general strength and energy

    (weakness, tiredness), headache, dizziness

  • rash, itchy skin
  • blood tests may show an increase in some

    liver enzymes

Uncommon (may affect up to 1 in 100 people)

  • bleeding into the brain or inside the skull

    (see above, signs of bleeding)

  • bleeding into a joint causing pain and swelling
  • thrombocytopenia (low number of platelets, which are cells that help blood to clot)
  • allergic reactions, including allergic skin reactions
  • impaired function of the liver (may be seen in tests performed by your doctor)
  • blood tests may show an increase in bilirubin, some pancreatic or liver enzymes or in the number of platelets
  • fainting
  • feeling unwell
  • faster heartbeat
  • dry mouth
  • hives

Rare (may affect up to 1 in 1,000 people)

  • bleeding into a muscle
  • cholestasis (decreased bile flow), hepatitis incl. hepatocellular injury (inflamed liver incl. liver injury)
  • yellowing of the skin and eye (jaundice)
  • localised swelling
  • collection of blood (haematoma) in the groin as a complication of the cardiac procedure where a catheter is inserted in your leg artery (pseudoaneurysm) Very rare (may affect up to 1 in 10,000 people)
  • accumulation of eosinophils, a type of white granulocytic blood cells that cause inflammation in the lung (eosinophilic pneumonia)

Not known (frequency cannot be estimated from the available data)

  • kidney failure after a severe bleeding
  • bleeding in the kidney sometimes with presence of blood in urine leading to inability of the kidneys to work properly (anticoagulant-related nephropathy
  • increased pressure within muscles of the legs or arms after a bleeding, which leads to pain, swelling, altered sensation, numbness or paralysis (compartment syndrome after a bleeding)

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website:

www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Rivaroxaban Umedica

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on each blister after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Crushed tablets

Crushed tablets are stable in water or apple puree for up to 4 hours.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Rivaroxaban Umedica contains

  • The active substance is rivaroxaban. Each tablet contains 2.5 mg of rivaroxaban.
  • The other ingredients are:

    Tablet core: Cellulose microcrystalline (E460); Croscarmellose sodium (E468); Lactose monohydrate; Hypromellose (E464); Sodium laurilsulfate (E487); Magnesium stearate (E470b). See section 2 “Rivaroxaban Umedica 2.5 mg film-coated tablets contains lactose and sodium”. Tablet film coat: Hypromellose-2910 (E464); Titanium dioxide (E171); Macrogol-3350 (E1521); Iron oxide yellow (E172)

What Rivaroxaban Umedica 2.5 mg film-coated tablets looks like and contents of the pack

Rivaroxaban Umedica 2.5 mg film-coated tablets are Yellow, approx. 6.3 mm round shaped film-coated tablets, debossed with 'RIV' on one side and '2.5' on other side.

They come

  • in PVC/PVDC Alu foil blisters in cartons of

    14, 20, 28, 30, 56, 60, 98, 168 or 196 film-coated tablets or

  • in unit dose PVC/PVDC Alu foil blisters in cartons of 10 x 1 or 100 x 1 or
  • in multipacks containing 10 packs, each containing 10 x 1 (100 film-coated tablets) Not all pack sizes may be marketed.

Marketing Authorisation Holder

Umedica Laboratories UK Ltd

Office No. G42

The Panorama Park Street

Ashford, England

TN24 8DF

Manufacturer

Elara Pharmaservices Limited

5 Garden Court,

Lockington Hall, Main Street,

Lockington Derby, United Kingdom, DE74 2RH

This medicinal product is authorised under the following names:

Rivaroxaban Umedica 2.5 mg film-coated tablets- PL 60528/0016

This leaflet was last revised in 03/2026

XXXXXX

V-03 t INR values should not be used as they are not a dependable measure of the anticoagulant activity of Rivaroxaban Umedica

I am under anticoagulation treatment with Rivaroxaban Umedica (rivaroxaban) In case of emergency,

please notify:

Please also notify: Information for health care providers:

Name:

Address:

Birth date: Weight:

Other medicines / conditions: Doctor's name:

Doctor's phone:

Doctor's Stamp:

Name:

Phone:

Relationship:

What should I know about Rivaroxaban Umedica?

t Rivaroxaban Umedica thins the blood, which prevents you from getting dangerous blood clots.

t Rivaroxaban Umedica must be taken exactly as prescribed by your doctor. To ensure optimal

protection from blood clots, never skip a dose.

t You must not stop taking

Rivaroxaban Umedica without first talking to your doctor as your risk of blood clots may increase.

t Tell your health care provider about any other medicines you are currently taking, took recently or

intend to start taking, before you start Rivaroxaban Umedica.

t Tell your health care provider that you are taking Rivaroxaban Umedica before any surgery or invasive procedure.

When should I seek advice from my health care provider?

When taking a blood thinner such as Rivaroxaban Umedica it is important to be aware of its possible side effects. Bleeding is the most common side effect. Do not start taking Rivaroxaban Umedica if you know you are at risk of bleeding, without first discussing this with your doctor. Tell your health care provider straight away if you have any signs or symptoms of bleeding such as the following:

t pain

t swelling or discomfort

t headache, dizziness or weakness

t unusual bruising, nosebleeds, bleeding of gums, cuts that take a long time to stop bleeding

t menstrual flow or vaginal bleeding that is heavier than normal

t blood in your urine which may be pink or brown, red or black stools

t coughing up blood, or vomiting blood or material that looks like coffee grounds

How do I take Rivaroxaban Umedica?

t To ensure optimal protection,

Rivaroxaban Umedica

  • 2.5 mg can be taken with or without food
  • 10 mg can be taken with or without food
  • 15 mg must be taken with food
  • 20 mg must be taken with food

    Oct 2025

    t Keep this card with you at all times t Present this card to every physician or dentist prior to treatment

    XXXXXX

    V-01

    Patient Alert Card

    Rivaroxaban Umedica 2.5 mg

    Rivaroxaban Umedica 10 mg

    Rivaroxaban Umedica 15 mg

    Rivaroxaban Umedica 20 mg

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 60528/0016

Last revision stated in the text: March 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Rivaroxaban Umedica 2.5 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Rivaroxaban
Strength 2.5 mg
Pharmaceutical form Oral tablet
Yellow, approx. 6.3 mm round shaped film-coated tablets, debossed with 'RIV' on one side and '2.5' on other side.
How is it taken Oral
Excipients Cellulose microcrystalline (E460), Croscarmellose sodium (E468), Lactose monohydrate, Hypromellose (E464), Sodium laurilsulfate (E487), Magnesium stearate (E470b), Hypromellose-2910 (E464), Titanium dioxide (E171), Macrogol-3350 (E1521), Iron oxide yellow (E172)
Pack sizes 56 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Antithrombotic agents, direct factor Xa inhibitors
  1. B Blood and blood forming organ drugs
    1. B01 Antithrombotic agents
      1. B01A Antithrombotic agents
        1. B01AF Direct factor Xa inhibitors
          1. B01AF01 rivaroxaban
Marketing authorisation PL 60528/0016 (first authorised 13 October 2025)
Marketing authorisation holder Umedica Laboratories UK Ltd
Codes GTIN 5061105990318 · BNF 02080200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.